Literature DB >> 30191748

Validation of the French Version of the Weiss Functional Impairment Rating Scale-Self-Report in a Large Cohort of Adult Patients With ADHD.

Jean-Arthur Micoulaud-Franchi1,2, Sébastien Weibel3,4, Margaret Weiss5,6, Marie Gachet7, Kelly Guichard1,2, Stéphanie Bioulac1,2, Pierre Philip1,2, Isabelle Jaussent8, Yves Dauvilliers8,9, Régis Lopez8,9.   

Abstract

Objective: To analyze the psychometric properties of the French version of the Weiss Functional Impairment Rating Scale-Self Report (WFIRS-S) in a large clinical sample of adults with ADHD. Method: Patients (N = 363) were diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) criteria. Psychometric properties of the French version of the WFIRS-S were tested including construct validity with a confirmatory factor analysis, internal structural validity with Cronbach's alpha coefficient, external validity by correlations with the Beck Depression Inventory-II (BDI-II), and the EuroQol five-dimension (EQ-5D) questionnaire.
Results: The confirmatory factor analysis found the following: root mean square error of approximation (RMSEA) = 0.061, 90% confidence interval (CI) = [0.058, 0.063]; comparative fit index (CFI) = 0.67. Cronbach's alpha coefficient was .91. Correlations with EQ-5D descriptive index, visual analogue scale (VAS) scores, and BDI-II scores were -0.48, -0.55, and 0.53, respectively.
Conclusion: The French version of the WFIRS-S is a psychometrically acceptable self-reported questionnaire for the multi-domain evaluation of functional impairments in adults with ADHD, for research and clinical purposes.

Entities:  

Keywords:  ADHD; Weiss Functional Impairment Rating Scale–Self-Report form; functional impairment; psychometric properties

Mesh:

Year:  2018        PMID: 30191748     DOI: 10.1177/1087054718797434

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  1 in total

1.  Feasibility of an Extensive Strategy for Adult Diagnosis of Attention Deficit Hyperactivity Disorder Among Patients Suffering From Substance Use Disorders.

Authors:  Norman Therribout; Emily Karsinti; Alix Morel; Alexandra Dereux; Florence Vorspan; Lucia Romo; Romain Icick
Journal:  Front Psychiatry       Date:  2022-06-28       Impact factor: 5.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.